Point72 Asset Management L.P. Buys 39,946 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT)

Point72 Asset Management L.P. increased its stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT) by 68.5% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 98,246 shares of the company’s stock after purchasing an additional 39,946 shares during the quarter. Point72 Asset Management L.P.’s holdings in Cellebrite DI were worth $1,654,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of CLBT. Point72 Asia Singapore Pte. Ltd. increased its position in shares of Cellebrite DI by 59.6% during the 2nd quarter. Point72 Asia Singapore Pte. Ltd. now owns 2,724 shares of the company’s stock valued at $33,000 after purchasing an additional 1,017 shares during the last quarter. Advisors Asset Management Inc. increased its position in shares of Cellebrite DI by 130.5% during the 3rd quarter. Advisors Asset Management Inc. now owns 3,077 shares of the company’s stock valued at $52,000 after purchasing an additional 1,742 shares during the last quarter. Public Employees Retirement Association of Colorado bought a new position in shares of Cellebrite DI during the 2nd quarter valued at approximately $71,000. Pathway Financial Advisers LLC increased its position in shares of Cellebrite DI by 1,583.8% during the 3rd quarter. Pathway Financial Advisers LLC now owns 4,378 shares of the company’s stock valued at $74,000 after purchasing an additional 4,118 shares during the last quarter. Finally, nVerses Capital LLC bought a new position in shares of Cellebrite DI during the 2nd quarter valued at approximately $103,000. Institutional investors own 45.88% of the company’s stock.

Cellebrite DI Trading Up 0.1 %

Shares of CLBT stock opened at $19.89 on Wednesday. Cellebrite DI Ltd. has a twelve month low of $7.91 and a twelve month high of $21.72. The stock has a market capitalization of $4.10 billion, a price-to-earnings ratio of -12.83, a P/E/G ratio of 2.91 and a beta of 1.51. The stock has a fifty day simple moving average of $18.73 and a two-hundred day simple moving average of $15.62.

Cellebrite DI (NASDAQ:CLBT) last issued its earnings results on Wednesday, November 6th. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.05. Cellebrite DI had a positive return on equity of 122.59% and a negative net margin of 82.28%. The business had revenue of $106.90 million during the quarter, compared to analysts’ expectations of $102.06 million. During the same period in the prior year, the business earned $0.09 EPS. The business’s revenue for the quarter was up 27.0% compared to the same quarter last year. Research analysts predict that Cellebrite DI Ltd. will post 0.32 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have commented on CLBT. TD Cowen upped their price objective on Cellebrite DI from $20.00 to $23.00 and gave the company a “buy” rating in a research report on Monday, September 23rd. Deutsche Bank Aktiengesellschaft upped their price objective on Cellebrite DI from $15.00 to $18.00 and gave the company a “buy” rating in a research report on Friday, August 16th. Craig Hallum upped their price objective on Cellebrite DI from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. Bank of America upped their price objective on Cellebrite DI from $13.00 to $17.00 and gave the company a “buy” rating in a research report on Friday, August 16th. Finally, Needham & Company LLC upped their price objective on Cellebrite DI from $17.00 to $21.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. Eight research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $20.29.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.